Development of an effective tuberculosis (TB) vaccine has suffered from an incomplete understanding of the correlates of protection against Mycobacterium tuberculosis (Mtb). Intravenous (i.v.) vaccination with Bacille Calmette–Guérin (BCG) provides nearly complete protection against TB in rhesus macaques, but the antibody response it elicits remains incompletely defined. Here we show that i.v. BCG drives superior antibody responses in the plasma and the lungs of rhesus macaques compared to
FAIRDOMHub makes use of some necessary cookies to provide its core functionality.
Additionally, we make use of Matomo to discover how people are using FAIRDOMHub in order to help us improve the service. To opt out of this, choose the "Allow only necessary cookies" or "Allow necessary cookies and embedded content" option.
You can modify your cookie preferences at any time here,
or from the link in the footer.